ASYS.6.30.14-10Q

Indicate by a check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. [X] Yes [ ] No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). [ X ] Yes [ ] No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):



	June 30, 2014		September 30, 2013
	(Unaudited)
Assets
Current Assets
Cash and cash equivalents	$	31,638	$	37,197
Restricted cash	3,084		5,134
Accounts receivable
Trade (less allowance for doubtful accounts of $3,041 and $638 at June 30, 2014, and September 30, 2013, respectively)	7,466		4,829
Unbilled and other	8,124		3,194
Inventories	18,298		22,001
Deferred income taxes	630		1,330
Refundable income taxes	—		7,580
Other	1,938		2,930
Total current assets	71,178		84,195
Property, Plant and Equipment - Net	10,087		11,066
Deferred Income Taxes - Long Term	1,260		1,260
Intangible Assets - Net	2,990		3,502
Goodwill	8,505		8,481
Other Assets - Long Term	2,499		2,443
Total Assets	$	96,519	$	110,947



	June 30, 2014			September 30, 2013
	(Unaudited)
Liabilities and Stockholders' Equity
Current Liabilities
Accounts payable	$	7,028		$	5,472
Accrued compensation and related taxes	4,071			3,778
Accrued warranty expense	766			1,454
Deferred profit	7,293			3,067
Customer deposits	4,123			11,253
Other accrued liabilities	5,889			10,140
Income taxes payable	6,040			6,170
Total current liabilities	35,210			41,334
Income Taxes Payable Long-Term	2,900			2,810
Total liabilities	38,110			44,144

Commitments and Contingencies

Stockholders' Equity
Preferred stock; 100,000,000 shares authorized; none issued	—			—
Common stock; $0.01 par value; 100,000,000 shares authorized; shares issued and outstanding: 9,844,995 and 9,550,809 at June 30, 2014, and September 30, 2013, respectively	98			96
Additional paid-in capital	81,447			79,610
Accumulated other comprehensive loss	(4,143		)	(4,556		)
Retained deficit	(17,806		)	(8,004		)
Total stockholders' equity	59,596			67,146
Noncontrolling interest	(1,187		)	(343		)
Total equity	58,409			66,803
Total Liabilities and Stockholders' Equity	$	96,519		$	110,947



	Three Months Ended June 30,						Nine Months Ended June 30,
	2014			2013			2014			2013
Revenues, net of returns and allowances	$	9,190		$	10,398		$	36,678		$	27,873
Cost of sales	7,453			8,648			27,416			22,639
Write-down of inventory	106			4,427			199			4,080
Gross profit (loss)	1,631			(2,677		)	9,063			1,154

Selling, general and administrative	4,103			5,443			13,504			13,682
Restructuring charges	—			182			—			879
Research and development	1,399			1,947			4,443			5,055
Operating loss	(3,871		)	(10,249		)	(8,884		)	(18,462		)

Interest and other income, net	43			143			130			187
Loss before income taxes	(3,828		)	(10,106		)	(8,754		)	(18,275		)

Income tax provision	1,325			2,560			1,885			1,280

Net loss	(5,153		)	(12,666		)	(10,639		)	(19,555		)

Add: net loss (income) attributable to noncontrolling interest	(104		)	565			837			1,169
Net loss attributable to Amtech Systems, Inc.	$	(5,257	)	$	(12,101	)	$	(9,802	)	$	(18,386	)

Loss Per Share:

Basic loss per share attributable to Amtech shareholders	$	(0.53	)	$	(1.27	)	$	(1.01	)	$	(1.93	)
Weighted average shares outstanding	9,843			9,539			9,694			9,524
Diluted loss per share attributable to Amtech shareholders	$	(0.53	)	$	(1.27	)	$	(1.01	)	$	(1.93	)
Weighted average shares outstanding	9,843			9,539			9,694			9,524



	Three Months Ended June 30,						Nine Months Ended June 30,
	2014			2013			2014			2013
Net loss	$	(5,153	)	$	(12,666	)	$	(10,639	)	$	(19,555	)
Foreign currency translation adjustment	(335		)	676			406			599
Comprehensive loss	(5,488		)	(11,990		)	(10,233		)	(18,956		)

Comprehensive (income) loss attributable to noncontrolling interest	(80		)	603			844			1,224
Comprehensive loss attributable to Amtech Systems, Inc.	$	(5,568	)	$	(11,387	)	$	(9,389	)	$	(17,732	)



	Nine Months Ended June 30,
	2014			2013
Operating Activities
Net loss	$	(10,639	)	$	(19,555	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,796			2,014
Write-down of inventory	199			4,080
Deferred income taxes	705			1,287
Non-cash share based compensation expense	603			2,313
Provision for allowance for doubtful accounts	1,309			305
Changes in operating assets and liabilities:
Restricted cash	2,078			(374		)
Accounts receivable	(10,798		)	6,334
Inventories	3,700			3,591
Income taxes refundable and payable, net	7,648			(12		)
Prepaid expenses and other assets	958			570
Accounts payable	1,524			(3,070		)
Accrued liabilities and customer deposits	(12,007		)	597
Deferred profit	6,168			(6,079		)
Net cash used in operating activities	(6,756		)	(7,999		)
Investing Activities
Purchases of property, plant and equipment	(214		)	(156		)
Net cash used in investing activities	(214		)	(156		)
Financing Activities
Proceeds from the exercise of stock options	1,136			—
Excess tax benefit of stock options	100			—
Net cash provided by financing activities	1,236			—
Effect of Exchange Rate Changes on Cash	175			243
Net Decrease in Cash and Cash Equivalents	(5,559		)	(7,912		)
Cash and Cash Equivalents, Beginning of Period	37,197			46,726
Cash and Cash Equivalents, End of Period	$	31,638		$	38,814

Supplemental Cash Flow Information:
Income tax refunds	$	6,779		$	18
Income tax payments	$	178		$	21

Nature of Operations and Basis of Presentation – Amtech Systems, Inc. (the “Company” or "Amtech") designs, assembles, sells and installs capital equipment and related consumables used in the manufacture of wafers, primarily for the solar and semiconductor industries. The Company is developing an ion implanter to provide its customers with a more complete solution for their next-generation high-efficiency solar cell production. The Company sells these products to manufacturers of solar cells, silicon wafers, and semiconductors worldwide, particularly in Asia, United States and Europe.

The Company serves niche markets in industries that are experiencing rapid technological advances and which historically have been very cyclical. Therefore, future profitability and growth depend on the Company’s ability to develop or acquire and market profitable new products and on its ability to adapt to cyclical trends.

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”), and consequently do not include all disclosures normally required by accounting principles generally accepted in the United States of America. In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements contain all adjustments necessary, all of which are of a normal and recurring nature, to present fairly our financial position, results of operations and cash flows. Certain information and note disclosures normally included in financial statements have been condensed or omitted pursuant to the rules and regulations of the SEC. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2013.

Principles of Consolidation – The condensed consolidated financial statements include the accounts of the Company, its wholly-owned subsidiaries and subsidiaries in which it has a controlling interest. The Company reports noncontrolling interests in consolidated entities as a component of equity separate from the Company's equity. All material intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Revenue Recognition – Revenue is recognized upon shipment of the Company’s proven technology equal to the sales price less the greater of (i) the fair value of undelivered services or (ii) the contingent portion of the sales price, which is generally 10-20% of the total contract price. The entire cost of the equipment relating to proven technology is recorded upon shipment. The remaining contractual revenue, deferred costs and installation costs are recorded upon the completion of installation at the customers’ premises and acceptance of the product by the customer.

For purposes of revenue recognition, proven technology means the Company has a history of at least two successful installations. New technology systems are those systems with respect to which the Company cannot demonstrate that it can meet the provisions of customer acceptance at the time of shipment. The full amount of revenue and costs of new technology shipments is recognized upon the completion of installation at the customers’ premises and acceptance of the product by the customer.

Concentrations of Credit Risk – Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of trade accounts receivable and cash. The Company’s customers, located throughout the world, consist of manufacturers of solar cells, semiconductors, semiconductor wafers, light-emitting diodes (LEDs) and micro-electro-mechanical systems (MEMS). Credit risk is managed by performing ongoing credit evaluations of the customers’ financial condition, by requiring significant deposits where appropriate, and by actively monitoring collections. Letters of credit are required of certain customers depending on the size of the order, type of customer or its creditworthiness, and its country of domicile. Reserves for potentially uncollectible receivables are maintained based on an assessment of collectability.

The Company maintains its cash, cash equivalents and restricted cash in multiple financial institutions. Balances in the United States (approximately 60% of total cash balances) are primarily invested in U.S. Treasuries or are in financial institutions insured by the Federal Deposit Insurance Corporation (FDIC). The remainder of the Company’s cash is maintained in banks in The Netherlands, France and China that are uninsured.

Restricted Cash – Restricted cash is $3.1 million and $5.1 million as of June 30, 2014, and September 30, 2013, respectively. The balance includes collateral for bank guarantees required by certain customers from whom deposits have been received in advance of shipment and cash received from research and development grants related to our ion implant technology to be used for research and development projects.

Accounts Receivable - Unbilled and Other – Unbilled and other accounts receivable consist mainly of the contingent portion of the sales price that is not collectible until successful installation of the product. These amounts are generally billed upon final customer acceptance. For the majority of these amounts, a liability has been accrued in deferred profit.

Property, Plant and Equipment – Property, plant and equipment are recorded at cost. Maintenance and repairs are charged to expense as incurred. The cost of property retired or sold and the related accumulated depreciation are removed from the applicable accounts when disposition occurs and any gain or loss is recognized. Depreciation is computed using the straight-line method. Useful lives for equipment, machinery and leasehold improvements range from three to seven years; for furniture and fixtures from five to ten years; and for buildings twenty years.



	June 30, 2014			September 30, 2013
	(dollars in thousands)
Land, building and leasehold improvements	$	11,068		$	10,960
Equipment and machinery	7,868			7,630
Furniture and fixtures	5,765			5,685
	24,701			24,275
Accumulated depreciation and amortization	(14,614		)	(13,209		)
	$	10,087		$	11,066



	Solar and Semiconductor Equipment			Polishing Supplies and Equipment		Total
	(dollars in thousands)
Balance at the beginning of year
Goodwill	$	12,563		$	728	$	13,291
Accumulated impairment losses	(4,810		)	—		(4,810		)
	7,753			728		8,481
Net exchange differences	24			—		24
Balance at the end of quarter
Goodwill	12,600			728		13,328
Accumulated impairment losses	(4,823		)	—		(4,823		)
	$	7,777		$	728	$	8,505



	Useful Life	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
		June 30, 2014							September 30, 2013
		(dollars in thousands)
Non-compete agreements	4-8 years	$	1,066	$	(902	)	$	164	$	1,065	$	(717	)	$	348
Customer lists	10 years	879		(601		)	278		871		(532		)	339
Technology	5-10 years	2,442		(1,664		)	778		2,426		(1,422		)	1,004
In-process research and development	(1)	1,600		—			1,600		1,600		—			1,600
Other	2-10 years	344		(174		)	170		341		(130		)	211
		$	6,331	$	(3,341	)	$	2,990	$	6,303	$	(2,801	)	$	3,502

Stock-Based Compensation - The Company measures compensation costs relating to share-based payment transactions based upon the grant-date fair value of the award. Those costs are recognized as expense over the requisite service period, which is generally the vesting period. The benefits of tax deductions in excess of recognized compensation cost are credited to additional paid-in capital and reported as cash flow from financing activities rather than as cash flow from operating activities.



	Three Months Ended June 30,						Nine Months Ended June 30,
	2014			2013			2014			2013
	(dollars in thousands)
Effect on income before income taxes (1)	$	(230	)	$	(1,553	)	$	(603	)	$	(2,313	)
Effect on income taxes	36			315			196			469
Effect on net income	$	(194	)	$	(1,238	)	$	(407	)	$	(1,844	)

Stock options issued under the terms of the plans have, or will have, an exercise price equal to or greater than the fair market value of the common stock at the date of the option grant and expire no later than 10 years from the date of grant, with the most recent grant expiring in 2023. Options issued by the Company vest over 2 to 4 years.



	Nine Months Ended June 30,
	2014					2013
	Options			Weighted Average Exercise Price		Options			Weighted Average Exercise Price
Outstanding at beginning of period	1,059,417			$	6.71	891,293			$	9.37
Granted	272,906			7.01		312,850			2.95
Exercised	(263,358		)	4.31		—			—
Forfeited	(4,546		)	8.71		(132,318		)	15.79
Outstanding at end of period	1,064,419			$	7.37	1,071,825			$	6.71

Exercisable at end of period	663,220			$	8.14	873,969			$	7.07
Weighted average fair value of options granted during the period	$	4.38				$	1.82

To estimate expected lives for this valuation, it was assumed that options will be exercised at varying schedules after becoming fully vested. Forfeitures have been estimated at the time of grant and will be revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Forfeitures were estimated based upon historical experience. Fair value computations are highly sensitive to the volatility factor assumed; the greater the volatility, the higher the computed fair value of the options granted. The Company uses historical stock prices to determine the volatility factor.

The Company awards restricted shares under the existing share-based compensation plans. The Company's restricted share awards vest in equal annual installments over a two to four-year period. The total value of these awards is expensed on a ratable basis over the service period of the employees receiving the grants. The “service period” is the time during which the employees receiving grants must remain employees for the shares granted to fully vest.



	Nine Months Ended June 30,
	2014				2013
	Awards		Weighted Average Grant Date Fair Value		Awards		Weighted Average Grant Date Fair Value
Beginning Outstanding	69,154		$	10.13	127,975		$	9.06
Released	(30,828	)	10.08		(55,646	)	7.65
Forfeited	—		—		(50	)	7.98
Ending Outstanding	38,326		$	10.17	72,279		$	10.15

In accordance with the requirements of the Fair Value Measurements and Disclosures Topic of the Financial Accounting Standards Board ("FASB") Accounting Standards Codification (ASC), the Company groups its financial assets and liabilities measured at fair value on a recurring basis in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value. These levels are:

In accordance with the requirements of the Fair Value Measurements and Disclosures Topic of the FASB ASC, it is the Company's policy to use observable inputs whenever reasonably practicable in order to minimize the use of unobservable inputs when developing fair value measurements. When available, the Company uses quoted market prices to measure fair value. If market prices are not available, the fair value measurement is based on models that use primarily market based parameters including interest rate yield curves, option volatilities and currency rates. In certain cases, where market rate assumptions are not available, the Company is required to make judgments about assumptions market participants would use to estimate the fair value of a financial instrument. Changes in the underlying assumptions used, including discount rates and estimates of future cash flows, could significantly affect the results of current or future values.

Cash, Cash Equivalents and Restricted Cash - Included in Cash and Cash Equivalents in the Condensed Consolidated Balance Sheets is $18.0 million and $18.5 million as of June 30, 2014 and September 30, 2013, respectively, of money market funds invested in treasury bills, notes and other direct obligations of the U.S. Treasury. The fair value of this cash equivalent is based on Level 1 inputs in the fair value hierarchy.

Receivables and Payables - The recorded amounts of these financial instruments, including accounts receivable and accounts payable, approximate their fair value because of the short maturities of these instruments. If measured at fair value in the financial statements, these financial instruments would be classified as Level 3 in the fair value hierarchy.

Pensions - The Company has retirement plans covering substantially all employees. The principal plans are the multiemployer defined benefit pension plans of the Company’s operations in The Netherlands and France and the plan for hourly union employees in Pennsylvania. The multiemployer plans in the United States and France are insignificant. The Company's defined contribution plans cover substantially all of the employees in the United States. The Company matches employee funds on a discretionary basis.

Shipping expense – Shipping expenses of $0.2 million and $0.3 million for the three months ended June 30, 2014 and 2013, respectively, are included in selling, general and administrative expenses. Shipping expenses of $0.7 million and $0.6 million for the nine months ended June 30, 2014 and 2013, respectively, are included in selling, general and administrative expenses.

Research and development expense – Research and development expenses consist of the cost of employees, consultants and contractors who design, engineer and develop new products and processes; materials and supplies used in those activities; and product prototyping. The Company receives reimbursements through governmental research and development grants which are netted against these expenses when certain conditions have been met. The table below shows gross research and development expenses and grants earned:



	Three Months Ended						Nine Months Ended
	June 30, 2014			June 30, 2013			June 30, 2014			June 30, 2013
	(dollars in thousands)						(dollars in thousands)
Research and development	$	3,054		$	2,158		$	8,442		$	6,801
Grants earned	(1,655		)	(211		)	(3,999		)	(1,746		)
Net research and development	$	1,399		$	1,947		$	4,443		$	5,055

In June 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-12 which provides guidance on how to account for shared-based payment awards where the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. The ASU requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. ASU 2014-12 is effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2015, and early adoption is permitted. We are currently assessing the impact of this ASU but do not expect it to have a material impact on our consolidated financial position and results of operations.

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which supersedes most of the current revenue recognition requirements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for these goods or services. New disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers are also required. This guidance is effective for the Company in the first quarter of fiscal year 2018 and early application is not permitted. Entities must adopt the new guidance using one of two retrospective application methods. The Company is currently evaluating the standard and the impact on our financial position and results of operations.

In April 2014, the FASB issued ASU No. 2014-08 "Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360)." The amendments in this Update change the requirements for reporting discontinued operations in Subtopic 205-20. A discontinued operation may include a component of an entity or a group of components of an entity, or a business or nonprofit activity.

A disposal of a component of an entity or a group of components of an entity is required to be reported in discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity's operations and financial results when any of the following occurs:

The amendments in this Update improve the definition of discontinued operations by limiting discontinued operations reporting to disposals of components of an entity that represent strategic shifts that have (or will have) a major effect on an entity's operations and financial results. Under current U.S. GAAP, many disposals, some of which may be routine in nature and not a change in an entity's strategy, are reported in discontinued operations.

The amendments in this Update also require an entity to disclose the pretax profit or loss (or change in net assets for a not-for-profit entity) of an individually significant component of an entity that does not qualify for discontinued operations reporting. The Board concluded that this disclosure should provide users with information about the financial effects of significant disposals that do not qualify for discontinued operations reporting.

In July 2013, the FASB issued ASU No. 2013-11 "Income Taxes (Topic 740)." An unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The assessment of whether a deferred tax asset is available is based on the unrecognized tax benefit and deferred tax asset that exist at the reporting date and should be made presuming disallowance of the tax position at the reporting date. The amendments in this Update are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013.

In March 2013, the FASB issued ASU No. 2013-05 "Foreign Currency Matters (Topic 830)." The objective of the amendments in this Update is to resolve the diversity in practice about which codification subtopic applies to the release of the cumulative translation adjustment into net income when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a business within a foreign entity. The amendments in this Update are effective prospectively for fiscal years (and interim reporting periods within those years) beginning after December 15, 2013. The Company will evaluate the impact of the Update as future transactions occur.

In February 2013, The FASB issued ASU No. 2013-04 "Liabilities (Topic 405)," The guidance in this Update requires an entity to measure obligations resulting from joint and several liability arrangements for which the total amount of the obligation within the scope of this guidance is fixed at the reporting date, as the sum of the following:

The guidance in this Update also requires an entity to disclose the nature and amount of the obligation as well as other information about those obligations. The amendments in this Update are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The Company does not expect this Update to have a material impact on the Company's consolidated financial statements.

The quarterly income tax provision is calculated using an estimated annual effective tax rate, based upon expected annual income, permanent items, statutory rates and planned tax strategies in the various jurisdictions in which the Company operates. However, losses in certain jurisdictions and discrete items are treated separately.

Deferred tax assets and liabilities reflect the tax effects of temporary differences between the carrying value of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The Company records a valuation allowance if, based on the weight of available evidence, it is more likely than not that some portion or all of a deferred tax asset will not be realized. Our expectations regarding realization of our deferred tax assets is based upon the weight of all available evidence, including such factors as our recent earnings history, expected future taxable income and available tax planning strategies. The Company maintains a valuation allowance with respect to certain state and foreign deferred tax assets that may not be recovered. Each quarter, the valuation allowance is re-evaluated. During the nine months ended June 30, 2014 the valuation allowance increased by $3.0 million due to net operating losses in China, The Netherlands and France and the recording of a valuation allowance on most of the previously recognized deferred tax assets in France.

The Company and one or more of its subsidiaries file income tax returns in The Netherlands, Germany, France, China and Hong Kong, as well as the U.S. and various states in the U.S. The Company and its subsidiaries have a number of open tax years dictated by statute in each of the respective taxing jurisdictions, but generally is from 3 to 5 years.

Basic earnings per share (EPS) is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted EPS is computed similarly to basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if potentially dilutive common shares had been issued. In the case of a net loss, diluted earnings per share is calculated in the same manner as basic EPS.

For the three and nine months ended June 30, 2014, options for 1,016,000 shares and 38,000 restricted stock awards are excluded from the diluted EPS calculations because they are anti-dilutive. For the three and nine months ended June 30, 2013, options for 1,064,000 shares and 38,000 restricted stock awards were excluded from the diluted EPS calculations because they were anti-dilutive.



	Three Months Ended June 30,						Nine Months Ended June 30,
	2014			2013			2014			2013
	(in thousands, except per share amounts)						(in thousands, except per share amounts)
Basic Loss Per Share Computation
Net loss attributable to Amtech Systems, Inc.	$	(5,257	)	$	(12,101	)	$	(9,802	)	$	(18,386	)
Weighted Average Shares Outstanding:
Common stock	9,843			9,539			9,694			9,524
Basic loss per share attributable to Amtech shareholders	$	(0.53	)	$	(1.27	)	$	(1.01	)	$	(1.93	)
Diluted Loss Per Share Computation
Net loss attributable to Amtech Systems, Inc.	$	(5,257	)	$	(12,101	)	$	(9,802	)	$	(18,386	)
Weighted Average Shares Outstanding:
Common stock	9,843			9,539			9,694			9,524
Common stock equivalents (1)	—			—			—			—
Diluted shares	9,843			9,539			9,694			9,524
Diluted loss per share attributable to Amtech shareholders	$	(0.53	)	$	(1.27	)	$	(1.01	)	$	(1.93	)

The Company’s products are classified into two business segments: the solar and semiconductor equipment segment and the polishing supplies segment. In the solar and semiconductor equipment segment, we are a leading supplier of thermal processing systems, including related automation, parts and services, to the solar/photovoltaic, semiconductor, silicon wafer and MEMS industries and also offer PECVD (plasma-enhanced chemical vapor deposition) equipment. In the polishing supplies segment, the Company produces consumables and machinery for lapping (fine abrading) and polishing of materials, such as sapphire substrates, optical components, silicon wafers, numerous types of crystal materials, ceramics and metal components.



	Three Months Ended						Nine Months Ended
	June 30, 2014			June 30, 2013			June 30, 2014			June 30, 2013
	(dollars in thousands)
Net Revenues:
Solar and semiconductor equipment	$	6,764		$	8,426		$	29,615		$	21,647
Polishing supplies and equipment	2,426			1,972			7,063			6,226
	$	9,190		$	10,398		$	36,678		$	27,873
Operating income (loss):
Solar and semiconductor equipment	$	(3,246	)	$	(7,719	)	$	(6,824	)	$	(13,271	)
Polishing supplies and equipment	654			315			1,622			847
Non-segment related	(1,279		)	(2,845		)	(3,682		)	(6,038		)
	$	(3,871	)	$	(10,249	)	$	(8,884	)	$	(18,462	)

During the three months ended June 30, 2014, one customer individually represented 14% of net revenues. During the three months ended June 30, 2013, two customers individually represented 48% and 11% of net revenues. During the nine months ended June 30, 2014, two customers individually represented 15% and 13% of net revenues. During the nine months ended June 30, 2013, one customer individually represented 24% of net revenues.

Development projects – In fiscal 2014, Tempress Systems, Inc. ("Tempress") entered into an agreement with the Energy Research Centre of the Netherlands ("ECN"), a Netherlands government sponsored research institute, for a joint research and development project. Under the terms of the agreement, Tempress sold an ion implanter ("Equipment") to ECN for $1.4 million. Both Tempress and ECN are performing research and development projects utilizing the Equipment at the ECN facilities. Each party to the agreement will have 100% rights to the results of the projects developed separately by the individual parties. Any results co-developed will be jointly owned. Over the four -year period of the agreement, Tempress is required to contribute $1.4 million to the project in the form of installation of the equipment, acceptance testing, project meeting attendance, training, parts, and service, including keeping the equipment in good condition and repair for the first two years of the agreement.

In 2013, Shanghai Kingstone Semiconductor Company Ltd. ("Kingstone") entered into an agreement with certain government agencies in Shanghai, China for the purpose of developing ion implant technology for non-solar applications. Kingstone has substantially completed the first phase of this development project and received $3.6 million of grant funds for the project. Under the arrangement, Kingstone has agreed that, in 2014, it will have in place $6.1 million of its commitment to the project. The remainder of Kingstone's commitment is to be in place by December 2015. Amtech owns 55% of Kingstone Technology Hong Kong Limited, which owns 100% of Shanghai Kingstone Semiconductor Company Ltd. Amtech has no obligation or plan to fund Kingstone's commitments under this agreement.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the related notes included in Item 1, “Condensed Consolidated Financial Statements” in this quarterly report on Form 10-Q and our consolidated financial statements and related notes included in Item 8, “Financial Statements and Supplementary Data” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2013.

Certain information contained or incorporated by reference in this Quarterly Report on Form 10-Q is forward-looking in nature. All statements included or incorporated by reference in this Quarterly Report on Form 10-Q, or made by management of Amtech Systems, Inc. and its subsidiaries (“the Company” or “Amtech”), other than statements of historical fact, are hereby identified as “forward-looking statements” (as such term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). In some cases, forward-looking statements can be identified by terminology such as “may,” “will,” “should,” “would,” “expects,” “plans,” “anticipates,” “intends,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology. Examples of forward-looking statements include statements regarding Amtech's future financial results, operating results, business strategies, projected costs, products under development, competitive positions and plans and objectives of the Company and its management for future operations.

We cannot guarantee that any forward-looking statement will be realized, although we believe that the expectations reflected in the forward-looking statements are reasonable. Achievement of future results is subject to risks, uncertainties and potentially inaccurate assumptions. The Form 10-K that we filed with the Securities and Exchange Commission for the year-ended September 30, 2013 listed various important factors that could affect Amtech's future operating results and financial condition and could cause actual results to differ materially from historical results and expectations based on forward-looking statements made in this document or elsewhere by Amtech or on its behalf. These factors can be found under the heading “Risk Factors” in the Form 10-K and investors should refer to them. Because it is not possible to predict or identify all such factors, any such list cannot be considered a complete set of all potential risks or uncertainties. Except as required by law, we undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events, or otherwise.

We operate in two segments: (i) the solar and semiconductor equipment segment and (ii) the polishing supplies segment. In our solar and semiconductor equipment segment, we are a leading supplier of thermal processing systems, including related automation, parts and services, to the solar/photovoltaic, semiconductor, silicon wafer and MEMS industries and also offer PECVD (plasma-enhanced chemical vapor deposition) equipment to the solar market. In our polishing supplies segment, we produce consumables and machinery for lapping (fine abrading) and polishing of materials, such as sapphire substrates, optical components, silicon wafers, numerous types of crystal materials, ceramics and metal components. Since the 2011 acquisition of Kingstone Technology Hong Kong, Limited ("Kingstone"), a holding company that owns 100% of Kingstone Semiconductor Company Ltd., a Shanghai-based technology company specializing in ion implant solutions for the solar industry, we have advanced the development of an ion implanter to provide our solar customers with a more complete solution for their next-generation high-efficiency solar cell production.

Our customers are primarily manufacturers of solar cells and integrated circuits. The solar cell and semiconductor industries are cyclical and historically have experienced significant fluctuations. Our revenue is impacted by these broad industry trends. In 2012 and 2013, the solar cell industry experienced a structural imbalance between supply and demand. This imbalance has negatively impacted our results of operations and is expected to do so in the future.

Our strategy has been, and continues to be, to grow the Company through strategic product development and acquisitions. In addition to internal product development, we have acquired companies with complementary products or products that serve adjacent process steps. In October 2007, we acquired R2D Automation SAS, which allowed us to provide our diffusion furnaces with integrated automation that is also sold as a stand-alone product. In February 2011, we acquired a 55% ownership interest in Kingstone.



	Three Months Ended				Nine Months Ended
	June 30, 2014		June 30, 2013		June 30, 2014		June 30, 2013
Net revenue	100	%	100	%	100	%	100	%
Cost of goods sold	81	%	83	%	75	%	81	%
Write-down of inventory	1	%	43	%	1	%	15	%
Gross margin	18	%	(26	)%	24	%	4	%
Operating expenses:
Selling, general and administrative	45	%	52	%	37	%	49	%
Restructuring charges	0	%	2	%	0	%	3	%
Research and development	15	%	19	%	12	%	18	%
Total operating expenses	60	%	73	%	49	%	70	%
Loss from operations	(42	)%	(99	)%	(25	)%	(66	)%
Interest income (expense), net	0	%	1	%	0	%	1	%
Loss before income taxes	(42	)%	(98	)%	(25	)%	(65	)%
Income taxes provision (benefit)	14	%	25	%	5	%	5	%
Net loss	(56	)%	(123	)%	(30	)%	(70	)%
Add: net loss (income) attributable to noncontrolling interest	(1	)%	5	%	2	%	4	%
Net loss attributable to Amtech Systems, Inc.	(57	)%	(118	)%	(28	)%	(66	)%

Net revenue consists of revenue recognized upon shipment or installation of products using proven technology and upon acceptance of products using new technology. In addition, spare parts sales are recognized upon shipment. Service revenue is recognized upon completion of the service activity or ratably over the term of the service contract. Since the majority of our revenue is generated from large system sales, revenue and operating income can be significantly impacted by the timing of system shipments, and recognition of revenue based on customer acceptances.



	Three months ended June 30,									Nine months ended June 30,
Segment	2014		2013		Inc (Dec)			%		2014		2013		Inc (Dec)		%
	(dollars in thousands)
Solar and semiconductor equipment segment	$	6,764	$	8,426	$	(1,662	)	(20	)%	$	29,615	$	21,647	$	7,968	37	%
Polishing supplies segment	2,426		1,972		454			23	%	7,063		6,226		837		13	%
Total net revenue	$	9,190	$	10,398	$	(1,208	)	(12	)%	$	36,678	$	27,873	$	8,805	32	%

Net revenue for the quarters ended June 30, 2014 and 2013 was $9.2 million and $10.4 million, respectively, a decrease of $1.2 million or 12%. Revenue from the solar and semiconductor equipment segment decreased 20% due primarily to revenue deferrals related to shipment of equipment that is considered to be new technology. According to our revenue recognition policy, 100% of the revenue for plasma-enhanced chemical vapor deposition (PECVD) equipment as well as revenue for ion implant equipment was deferred, because it is considered new technology until the customer's defined specifications have been met for two similarly configured systems and processes. Net revenue from the solar market was $2.1 million and $6.5 million for the three months ended June 30, 2014 and 2013, respectively. The current supply / demand imbalance and global economic conditions have continued to negatively impact sales in the solar equipment market and have caused our customers to significantly slow or push out their capacity expansion plans, and it is difficult to predict when the overall market will improve. Partially offsetting the decrease in solar net revenues were increased revenues from our semiconductor equipment customers who increased their capital equipment purchases.

Net revenue for the nine months ended June 30, 2014 and 2013 was $36.7 million and $27.9 million, respectively, an increase of $8.8 million or 32%. Revenue from the solar and semiconductor equipment segment increased 37% due primarily to an upturn in our semiconductor customers' capital equipment purchases. Net revenue from the solar market was $14.8 million and $14.6 million for the nine months ended June 30, 2014, and 2013, respectively. The large shipments of n-type cell technology in fiscal 2014 were partially offset by deferred revenue due to the significant amount of new product shipped.

Increased revenues from the polishing supplies segment resulted from significant increases in sales of polishing templates, which are used in single-sided polishing processes. Sales of polishing templates have improved due primarily to the increased demand for sapphire substrates used in LED lighting and mobile communication devices.

Our order backlog as of June 30, 2014 and 2013 was $39.4 million and $24.8 million, respectively, an increase of 59%. Our backlog as of June 30, 2014 includes approximately $30.6 million of orders and deferred revenue from our solar industry customers, compared to $19.3 million at June 30, 2013. New orders booked in the quarter ended June 30, 2014 were $17.9 million versus $20.7 million of customer orders in the quarter ended June 30, 2013. As of June 30, 2014, two customers individually accounted for 20% and 19% of our backlog. The orders included in our backlog are generally credit approved customer purchase orders expected to ship within the next twelve months. Because our orders are typically subject to cancellation or delay by the customer, our backlog at any particular point in time is not necessarily representative of actual sales for succeeding periods, nor is backlog any assurance that we will realize profit from completing these orders. Our backlog also includes revenue deferred pursuant to our revenue recognition policy, derived from orders that have already been shipped, but which have not met the criteria for revenue recognition.

Gross profit is the difference between net revenue and cost of goods sold plus write-down of inventory. Cost of goods sold consists of purchased material, labor and overhead to manufacture equipment and spare parts and the cost of service and support to customers for installation, warranty and paid service calls. Gross margin is gross profit as a percent of net revenue.



	Three Months Ended June 30,									Nine months ended June 30,
Segment	2014		2013			Inc (Dec)		%		2014		2013			Inc (Dec)		%
	(dollars in thousands)
Solar and semiconductor equipment segment	$	569	$	(3,411	)	$	3,980	117	%	$	6,262	$	(702	)	$	6,964	992	%
Polishing supplies segment	1,062		734			328		45	%	2,801		1,856			945		51	%
Total gross profit (loss)	$	1,631	$	(2,677	)	$	4,308	161	%	$	9,063	$	1,154		$	7,909	685	%

Gross profit (loss) for the three months ended June 30, 2014 and 2013 was $1.6 million and $(2.7) million, respectively; an increase of $4.3 million. Gross margin on products from our solar and semiconductor equipment segment was 8% in the quarter ended June 30, 2014, compared to (40)% in the quarter ended June 30, 2013. Gross margins in the third quarter of fiscal 2014 were 8% due to lower levels of revenue, higher levels of deferred revenue and sales of new products with higher initial costs, partially offset by a benefit from the cancellation of inventory purchase orders and utilization of previously written-down inventory. Negative gross margins in the third quarter of fiscal 2013 were primarily due to inventory write-downs of $4.4 million. In the quarter ended June 30, 2014, we deferred profit of $1.9 million compared to a net recognition of previously-deferred profit of $0.8 million in the quarter ended June 30, 2013.

Gross profit for the nine months ended June 30, 2014 and 2013 was $9.1 million and $1.2 million, respectively; an increase of $7.9 million. Gross margin on products from our solar and semiconductor equipment segment was 21% in the nine months ended June 30, 2014, compared to (3)% in the nine months ended June 30, 2013. Improved utilization of manufacturing capacity with increased sales volumes as well as expense reductions from company-wide cost-control initiatives favorably impacted the gross margins. The gross margin for the first nine months of fiscal 2014 also benefited, in part, from the use of $2.2 million of previously-written down inventory and $1.0 million of revenue from a second quarter sales order cancellation. In the nine months ended June 30, 2014, we deferred profit of $6.2 million compared to net recognition of previously-deferred profit of $6.1 million in the nine months ended June 30, 2013.

Gross margin on products from our polishing supplies segment was 44% and 40% respectively for the three and nine months ended June 30, 2014. Gross margin for the three and nine months ended June 30, 2013 was 37% and 30%, respectively. Higher margins in this segment resulted primarily from improved operational efficiencies associated with increased sales of templates.



	Three Months Ended June 30,									Nine months ended June 30,
Segment	2014		2013		Inc (Dec)			%		2014		2013		Inc (Dec)			%
	(dollars in thousands)
Solar and semiconductor equipment segment	$	3,578	$	4,888	$	(1,310	)	(27	)%	$	11,973	$	12,069	$	(96	)	(1	)%
Polishing supplies segment	525		555		(30		)	(5	)%	1,531		1,613		(82		)	(5	)%
Total selling, general and administrative expenses	$	4,103	$	5,443	$	(1,340	)	(25	)%	$	13,504	$	13,682	$	(178	)	(1	)%

Selling, general and administrative (SG&A) expenses for the three months ended June 30, 2014 and 2013 were $4.1 million and $5.4 million , respectively. The decrease results from lower stock-based compensation expense which was $0.2 million and $1.6 million for the respective three month periods.

SG&A expenses for the nine month periods ended June 30, 2014 and 2013 were $13.5 million and $13.7 million, respectively. This includes $0.6 million and $2.3 million of stock-based compensation for the respective nine month periods. The decrease in stock-based compensation expenses in Fiscal 2014 was partially offset by bad debt expense of $1.3 million related to financial difficulties being encountered by certain customers. Collection efforts and negotiations of continued service of these customers

Research and development expenses consist of the cost of employees, consultants and contractors who design, engineer and develop new products and processes as well as materials and supplies used in producing prototypes. Reimbursement of research and development costs in the form of governmental research and development grants are netted against these expenses.



	Three Months Ended June 30,											Nine Months Ended June 30,
	2014			2013			Incr. (Decr.)			% change		2014			2013			Incr. (Decr.)			% change
	(dollars in thousands)											(dollars in thousands)
Research and development	$	3,053		$	2,158		$	895		41	%	$	8,442		$	6,801		$	1,641		24	%
Grants earned	(1,654		)	(211		)	(1,443		)	684	%	(3,999		)	(1,746		)	(2,253		)	129	%
Net research and development	$	1,399		$	1,947		$	(548	)	(28	)%	$	4,443		$	5,055		$	(612	)	(12	)%

Research and development ("R&D") expense (net of grants earned) for the three months ended June 30, 2014 decreased $0.5 million compared to the three months ended June 30, 2013. For the nine months ended June 30, 2014, R&D expense, net of grants earned decreased $0.6 million from net R&D expense for the nine months ended June 30, 2013. The decrease in net R&D expense is due to the recognition of a significant amount of government grant funding. Gross R&D spending increased due primarily to higher activity in the development of equipment for the solar industry, as well as ion implant technology for markets other than solar.

As described in our Annual report on Form 10-K for the fiscal year ended September 30, 2013, our Kingstone subsidiary has entered into an agreement for the development of ion implant technology in China for markets other than solar. Depending on its progress, as well as the timing of grant recognition, this development project may result in a significant quarter-to-quarter fluctuations in research and development expenses.

For the three month and nine month periods ended June 30, 2014 we recorded income tax expense of $1.3 million and $1.9 million, respectively. For the three months and nine months ended June 30, 2013 we recorded income tax of $2.6 million and $1.3 million, respectively. The income tax provisions are based upon estimates of annual income, annual permanent differences and statutory tax rates in the various jurisdictions in which we operate, except that certain loss jurisdictions and discrete items are treated separately. No tax benefit has been recognized for losses related to Kingstone's ion implant development project, because Kingstone does not have a sufficient history of earnings. No tax benefit has been recognized for losses related to the Netherlands and France operations due to cumulative losses in the Netherlands and France.

The Financial Accounting Standards requires that a valuation allowance be established when it is “more likely than not” that all or a portion of deferred tax assets will not be realized. A review of all available positive and negative evidence needs to be considered, including a company’s performance, the market environment in which the company operates and the length of carryback and carryforward periods. According to those standards, it is difficult to conclude that a valuation allowance is not needed when the negative evidence includes cumulative losses in recent years. Therefore, cumulative losses weigh heavily in the overall assessment. As a result of the review as of June 30, 2014, we concluded that it was appropriate to increase the valuation allowance for the net net operating losses incurred this year in China, the Netherlands and France where cumulative losses have been incurred, and for most of the previously recognized deferred assets in France. Available tax planning strategies cause us to believe that it is more likely than not the deferred tax assets related to the United States tax jurisdiction will be realized despite cumulative losses there.

Our future effective income tax rate depends on various factors, such as the amount of income (loss) in each tax jurisdiction, tax regulations governing each region, non-tax deductible expenses incurred as a percent of pre-tax income and the effectiveness of our tax planning strategies. At the end of 2011, we restructured our European operations to lower the tax rate on the Netherlands operations from 35% to a marginal rate of 25%, as we intend to permanently reinvest future Dutch earnings in our foreign operations. The effect of the restructure on our tax rate depends on the amount of income or loss earned in the Netherlands.

At June 30, 2014, and September 30, 2013, cash and cash equivalents were $31.6 million and $37.2 million, respectively. At June 30, 2014, and September 30, 2013, restricted cash was $3.1 million and $5.1 million, respectively. Our working capital was $36.0 million as of June 30, 2014 and $42.9 million as of September 30, 2013.

The decrease in cash for the first nine months of fiscal 2014 of $5.6 million was primarily due to cash used in operating activities of $6.8 million, partially offset by cash provided by financing activities, both discussed below. We maintain a portion of our cash and cash equivalents in Euros at our Dutch and French operations; therefore, changes in the exchange rate have an impact on our cash balances. Our ratio of current assets to current liabilities was 2.0:1 and 2.0:1 as of June 30, 2014, and September 30, 2013, respectively.

The success of our growth strategy is dependent upon the availability of additional capital resources on terms satisfactory to management. Our sources of capital in the past have included the sale of equity securities, which include common and preferred stock sold in private transactions and public offerings, capital leases and long-term debt. We believe that our principal sources of liquidity discussed above are sufficient to support operations for at least the next twelve months.

Cash used in our operating activities was $6.8 million for the nine months ended June 30, 2014, compared to $8.0 million used by such activities for the nine months ended June 30, 2013. During the nine months ended June 30, 2014, $6.0 million was used as a result of investments in new products and the net loss from operations, adjusted for non-cash charges. Increases in accounts receivable and decreases in accrued liabilities and customer deposits were significant uses of cash during the first nine months of fiscal 2014, partially offset by decreases in inventory and receipt of refundable income taxes.

“Management’s Discussion and Analysis of Financial Condition and Results of Operations” discusses our condensed consolidated financial statements that have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the condensed consolidated financial statements, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period.

On an ongoing basis, we evaluate our estimates and judgments, including those related to revenue recognition, inventory valuation, accounts and notes receivable collectability, warranty and impairment of long-lived assets. We base our estimates and judgments on historical experience and on various other factors that we believe to be reasonable under the circumstances. The results of these estimates and judgments form the basis for making conclusions about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

A critical accounting policy is one that is both important to the presentation of our financial position and results of operations, and requires management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. These uncertainties are discussed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended September 30, 2013. We believe our critical accounting policies relate to the more significant judgments and estimates used in the preparation of our consolidated financial statements.

We believe the critical accounting policies discussed in the section entitled “Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2013 represent the most significant judgments and estimates used in the preparation of our consolidated financial statements. There have been no significant changes in our critical accounting policies during the nine months ended June 30, 2014.

We are exposed to foreign currency exchange rates to the extent sales contracts, purchase contracts, assets or liabilities of our operations are denominated in currencies other than their functional currency. Our operations in the United States are conducted in their functional currency, the U.S. dollar. Our operations in Europe and China conduct business primarily in their functional currencies, the Euro and Renminbi, respectively, and occasionally enter into transactions in the U.S. dollar. It is highly uncertain how currency exchange rates will fluctuate in the future. Actual changes in foreign exchange rates could adversely affect our operating results or financial condition.

During fiscal 2013 and in the first nine months of fiscal 2014, we did not hold any stand-alone or separate derivative instruments. We incurred net foreign currency transaction gains or losses of less than $0.1 million during the nine months ended June 30, 2014 and 2013. As of June 30, 2014, our foreign subsidiaries had $0.8 million of assets (cash and accounts receivable) denominated in currencies other than their functional currency. A 10% change in the value of the functional currency relative to the non-functional currency would result in a gain or loss of $0.1 million. As of June 30, 2014, we had $1.0 million of accounts payable, consisting of amounts owed by our foreign subsidiaries to our U.S. companies, denominated in U.S. dollars. Although the intercompany accounts are eliminated in consolidation, a 10% change in the value of the Euro relative to the U.S. dollar would result in a gain or loss of less than $0.1 million.

We incurred foreign currency translation gains of $0.4 million and $0.7 million during the nine months ended June 30, 2014, and 2013, respectively, a type of other comprehensive income (loss), which is a direct adjustment to stockholders’ equity. Our net investment in and advances to our foreign operations totaled $34.3 million as of June 30, 2014. A 10% change in the value of the foreign currencies relative to the U.S. dollar would cause approximately $3.4 million of other comprehensive income (loss). The risk associated with foreign currency translation adjustments has increased with our 2011 acquisition in China.

During the nine months ended June 30, 2014 and 2013, U.S. dollar denominated sales of our European operations were $1.4 million and $1.2 million, respectively. As of June 30, 2014, sales commitments denominated in a currency other than the functional currency of our transacting operation totaled $0.5 million. Our lead-times to fulfill these commitments generally range between 13 and 26 weeks. A 10% change in the relevant exchange rates between the time the order was taken and the time of shipment would not cause our gross profit on such orders to be significantly greater or less than expected on the date the order was taken. As of June 30, 2014, purchase commitments denominated in a currency other than the functional currency of our transacting operation totaled $0.2 million. A 10% change in the relevant exchange rates between the time the purchase order was placed and the time the order is received would not cause our cost of such items to be significantly greater or less than expected on the date the purchase order was placed.

Our management, including the Chief Executive Officer (“CEO”) and the Chief Financial Officer (“CFO”), has carried out an evaluation of the effectiveness of our disclosure controls and procedures as of June 30, 2014, pursuant to Exchange Act Rules 13a-15(e) and 15(d)-15(e). Disclosure controls and procedures means controls and other procedures that are designed to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to management, including the principal executive and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Based upon that evaluation, our CEO and CFO have concluded that as of such date, our disclosure controls and procedures in place were effective.

There have been changes to Amtech’s internal control over financial reporting during the nine months ended June 30, 2014. These changes to controls surrounding our revenue recognition process include: (1) additional training for appropriate personnel regarding revenue recognition; (2) modified checklists and forms to aid in application of the Company's revenue recognition policies; (3) implemented additional review procedures surrounding the revenue recognition process.

The most significant risk factors applicable to Amtech are described in Part I, Item 1A (Risk Factors) of Amtech’s Annual Report on Form 10-K for the fiscal year ended September 30, 2013 (our “2013 Form 10-K”). There have been no material changes to the risk factors previously disclosed on our fiscal 2013 Form 10-K.



10.1	Amtech Systems, Inc. Non-Employee Directors Stock Option Plan, as amended effective May 8, 2014 (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC May 14, 2014).

10.2	Amtech Systems, Inc. 2007 Employee Stock Incentive Plan, as amended effective May 8, 2014 (incorporated herein by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed with the SEC May 14, 2014).

31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as Amended	*

31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as Amended	*

32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	*

32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	*

101.INS	XBRL Instance Document	**

101.SCH	XBRL Taxonomy Extension Schema Document	**

101.PRE	Taxonomy Presentation Linkbase Document	**

101.CAL	XBRL Taxonomy Calculation Linkbase Document	**

101.LAB	XBRL Taxonomy Label Linkbase Document	**

101.DEF	XBRL Taxonomy Extension Definition Linkbase Document	**



Arizona	86-0411215
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

131 South Clark Drive, Tempe, Arizona	85281
(Address of principal executive offices)	(Zip Code)



Large accelerated filer [ ]	Accelerated filer [ ]

Non-accelerated filer [X] (Do not check if a smaller reporting company)	Smaller Reporting Company [ ]



	Page
PART I. FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements
Condensed Consolidated Balance Sheets June 30, 2014 (Unaudited) and September 30, 2013	3
Condensed Consolidated Statements of Operations (Unaudited) Three and Nine Months Ended June 30, 2014 and 2013	5
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Three and Nine Months Ended June 30, 2014 and 2013	6
Condensed Consolidated Statements of Cash Flows (Unaudited) Nine Months Ended June 30, 2014 and 2013	7
Notes to Condensed Consolidated Financial Statements (Unaudited)	8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Caution Regarding Forward-Looking Statements	19
Overview	19
Results of Operations	19
Liquidity and Capital Resources	23
Off-Balance Sheet Arrangements	23
Contractual Obligations	23
Critical Accounting Policies	24
Impact of Recently Issued Accounting Pronouncements	24
Item 3. Quantitative and Qualitative Disclosures About Market Risk	24
Item 4. Controls and Procedures	25
PART II. OTHER INFORMATION
Item 1. Legal Proceedings	26
Item 1A. Risk Factors	26
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	26
Item 3. Defaults Upon Senior Securities	26
Item 4. Mine Safety Disclosures	26
Item 5. Other Information	26
Item 6. Exhibits	26
SIGNATURES	28



	June 30, 2014		September 30, 2013
	(dollars in thousands)
Purchased parts and raw materials	$	10,874	$	11,757
Work-in-process	4,693		7,104
Finished goods	2,731		3,140
	$	18,298	$	22,001



	Nine Months Ended June 30,
	2014			2013
	(dollars in thousands)
Beginning balance	$	1,454		$	2,687
Warranty expenditures	(663		)	(1,137		)
Warranty provisions/(adjustment)	(25		)	216
Ending balance	$	766		$	1,766



[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


(1)	The in-process research and development will be amortized over its useful life when it has reached technological feasibility.


(1)	Stock-based compensation expense is included in selling, general and administrative expenses.


(1)	The number of common stock equivalents is calculated using the treasury stock method and the average market price during the period.


Item 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS


Item 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK


Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.



By	/s/ Bradley C. Anderson	Dated:	August 7, 2014
	Bradley C. Anderson
	Executive Vice President - Finance/Chief Financial Officer
	(Principal Accounting Officer)


•	Overview